Endocrine Therapy Clinical Trials

5 recruiting

Endocrine Therapy Trials at a Glance

7 actively recruiting trials for endocrine therapy are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Shanghai, Changsha, and Columbus. Lead sponsors running endocrine therapy studies include Fudan University, Hongmei Zheng, PhD, and Hunan Cancer Hospital.

Browse endocrine therapy trials by phase

Treatments under study

About Endocrine Therapy Clinical Trials

Looking for clinical trials for Endocrine Therapy? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Endocrine Therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Endocrine Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Early Phase 1

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+20 more
Ohio State University Comprehensive Cancer Center50 enrolled1 locationNCT05417308
Recruiting
Phase 3

Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)

Breast CancerAbemaciclibLocoregional Recurrence+1 more
Japanese Foundation for Cancer Research290 enrolled1 locationNCT07190443
Recruiting

Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

Breast CancerEndocrine TherapyCDK4/6 Inhibitors+1 more
Hunan Cancer Hospital300 enrolled1 locationNCT06033287
Recruiting

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Breast Cancer FemaleEndocrine Therapy
Hongmei Zheng, PhD1,200 enrolled1 locationNCT06050109
Recruiting
Not Applicable

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Advanced HR - Positive, HER2 - Negative Breast CancerResistant to (Neo)Adjuvant Endocrine Therapy
Fudan University36 enrolled1 locationNCT06856200
Recruiting
Not Applicable

AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial

Breast CancerAromatase InhibitorsEndocrine Therapy+1 more
Fudan University80 enrolled1 locationNCT06642948
Recruiting

Assessment of Brain Cognitive Impairment in Breast Cancer

Breast CancerEndocrine TherapyChemo-brain
Tang-Du Hospital90 enrolled1 locationNCT05305092